BMO Downgrades Ionis Pharma After Platelet Concerns Spill Over To Volanesorsen

By: via Benzinga
Shares of Ionis Pharmaceuticals Inc (NASDAQ: IONS) lost 39.42 percent on Thursday after the company announced that GlaxoSmithKline plc ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.